Optimization of an oral mucosa in vitro model based on cell line TR146

References

• Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 2001;52242:1–22.
   Google Scholar
• Drobitch RK, Svensson CK. Therapeutic drug monitoring in saliva. Clin Pharmacokinet. 1992;23:365–379. doi:10.2165/00003088-199223050-00003.
   PubMed Web of Science ®Google Scholar
• Haeckel R, Hänecke P. The application of saliva, sweat and tear fluid for diagnostic purposes. Ann Biol Clin. 1993;51:903–910.
   PubMed Web of Science ®Google Scholar
• Yoshizawa JM, Schafer CA, Schafer JJ, Farrell JJ, Paster BJ, Wong DTW. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin. Microbiol. Rev. 2013;26:781–791.
   PubMed Web of Science ®Google Scholar
• Jasim H, Carlsson A, Hedenberg-Magnusson B, Ghafouri B, Ernberg M. Saliva as a medium to detect and measure biomarkers related to pain. Sci Rep. 2018;8:1–9. doi:10.1038/s41598-018-21131-4.
   PubMed Web of Science ®Google Scholar
• Francois M, Leifert W, Martins R, Thomas P, Fenech M. Biomarkers of Alzheimer’s disease risk in peripheral tissues; focus on buccal cells. Curr Alzheimer Res. 2014;11:519–531. doi:10.2174/1567205011666140618103827.
   PubMed Web of Science ®Google Scholar
• François M, F. Fenech M, Thomas P, Hor M, Rembach A, N. Martins R, R. Rainey-Smith S, L. Masters C, Ames D, C. Rowe C, et al. High content, multi-parameter analyses in buccal cells to identify Alzheimer’s disease. Curr. Alzheimer Res. 2016;13:787–799.
   PubMed Web of Science ®Google Scholar
• Nielsen HM, Rassing MR. TR146 cells grown on filters as a model of human buccal epithelium: III. Permeability enhancement by different pH values, different osmolality values, and bile salts. Int J Pharm. 1999;185:215–225. doi:10.1016/S0378-5173(99)00165-9.
   PubMed Web of Science ®Google Scholar
• Jacobsen J, van Deurs B, Pedersen M, Rassing MR. TR146 cells grown on filters as a model for human buccal epithelium: I. Morphology, growth, barrier properties, and permeability. Int J Pharm. 1995;125:165–184. doi:10.1016/0378-5173(95)00109-V.
   Web of Science ®Google Scholar
• Mørck Nielsen H, Rømer Rassing M. TR 146 cells grown on filters as a model of human buccal epithelium: V. Enzyme activity of the TR146 cell culture model, human buccal epithelium and porcine buccal epithelium, and permeability of leu-enkephalin. Int J Pharm. 2000;200:261–270. doi:10.1016/S0378-5173(00)00394-X.
   PubMedGoogle Scholar
• Jacobsen J, Nielsen EB, Brondum-Nielsen K, Christensen ME, Olin HBD, Tommerup N, Rassing MR. Filter-grown TR146 cells as an in vitro model of human buccal epithelial permeability. Eur J Oral Sci. 1999;107:138–146.
   PubMed Web of Science ®Google Scholar
• Nielsen HM, Rassing MR. TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone and β-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa. Int J Pharm. 2000;194:155–167. doi:10.1016/S0378-5173(99)00368-3.
   PubMedGoogle Scholar
• Novakova I, Subileau E-A, Toegel S, Gruber D, Lachmann B, Urban E, Chesne C, Noe CR, Neuhaus W, et al. Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models. PLoS One. 2014;9:1–14.
   Web of Science ®Google Scholar
• Neuhaus W, Plattner VE, Wirth M, Germann B, Lachmann B, Gabor F, Noe CR. Validation of in vitro cell culture models of the blood–brain barrier: tightness characterization of two promising cell lines. J Pharm Sci. 2008;97:5158–5175.
   PubMed Web of Science ®Google Scholar
• Ramme AP, Koenig L, Hasenberg T, Schwenk C, Magauer C, Faust D, Lorenz AK, Krebs A, Drewell C, Schirrmann K, et al. Towards an autologous iPSC-derived patient-on-a-chip. bioRxiv 376970. 2018. doi:10.1101/376970.
   Google Scholar
• Gerhartl A, Hahn K, Neuhoff A, Friedl H-P, Förster CY, Wunder C, Schick M, Burek M, Neuhaus W. Hydroxyethylstarch (130/0.4) tightens the blood-brain barrier in vitro. Brain Res. 2020;1727:146560.
   PubMed Web of Science ®Google Scholar
• Neuhaus W, Samwer F, Kunzmann S, Muellenbach RM, Wirth M, Speer CP, Roewer N, Förster CY. Lung endothelial cells strengthen, but brain endothelial cells weaken barrier properties of a human alveolar epithelium cell culture model. Differentiation. 2012;84:294–304. doi:10.1016/j.diff.2012.08.006.
   PubMed Web of Science ®Google Scholar
• Neuhaus W, Gaiser F, Mahringer A, Franz J, Riethmüller C, Förster C. The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier. Front Cell Neurosci. 2014;8:1–16.
   PubMed Web of Science ®Google Scholar
• Bierbaumer L, Schwarze UY, Gruber R, Neuhaus W. Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier properties. Tissue Barriers. 2018;1–42. doi:10.1080/21688370.2018.1479568.
   Web of Science ®Google Scholar
• Colley HE, Hearnden V, Jones AV, Weinreb PH, Violette SM, MacNeil S, Thornhill MH, Murdoch C. Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma. Br J Cancer. 2011;105:1582–1592.
   PubMed Web of Science ®Google Scholar
• Buskermolen JK, Reijnders CMA, Spiekstra SW, Steinberg T, Kleverlaan CJ, Feilzer AJ, Bakker AD, Gibbs S. Development of a full-thickness human gingiva equivalent constructed from immortalized keratinocytes and fibroblasts. Tissue Eng Part C Methods. 2016;22:781–791.
   PubMed Web of Science ®Google Scholar
• Jennings LR, Colley HE, Ong J, Panagakos F, Masters JG, Trivedi HM, Murdoch C, Whawell S. Development and characterization of in vitro human oral mucosal equivalents derived from immortalized oral keratinocytes. Tissue Eng Part C Methods. 2016;22:1108–1117. doi:10.1089/ten.tec.2016.0310.
   PubMed Web of Science ®Google Scholar
• Dalley AJ, Abdulmajeed AA, Upton Z, Farah CS. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75NTR in malignancy. J Oral Pathol Med. 2013;42:37–46. doi:10.1111/j.1600-0714.2012.01170.x.
   PubMed Web of Science ®Google Scholar
• Dongari-Bagtzoglou A, Kashleva H. Development of a highly reproducible three-dimensional organotypic model of the oral mucosa. Nat Protoc. 2006;1:2012–2018. doi:10.1038/nprot.2006.323.
   PubMed Web of Science ®Google Scholar
• Zanetti F, Sewer A, Mathis C, Iskandar AR, Kostadinova R, Schlage WK, Leroy P, Majeed S, Guedj E, Trivedi K, et al. Systems toxicology assessment of the biological impact of a candidate modified risk tobacco product on human organotypic oral epithelial cultures. Chem Res Toxicol. 2016;29:1252–1269.
   PubMed Web of Science ®Google Scholar
• Koschier F, Kostrubsky V, Toole C, Gallo MA. In vitro effects of ethanol and mouth rinse on permeability in an oral buccal mucosal tissue construct. Food Chem Toxicol. 2011;49:2524–2529. doi:10.1016/j.fct.2011.06.018.
   PubMed Web of Science ®Google Scholar
• Lu Q, Jayatilake JAMS, Samaranayake LP, Jin L. Hyphal invasion of Candida albicans inhibits the expression of human β-defensins in experimental oral candidiasis. J Invest Dermatol. 2006;126:2049–2056. doi:10.1038/sj.jid.5700346.
   PubMed Web of Science ®Google Scholar
• Green CB, Cheng G, Chandra J, Mukherjee P, Ghannoum MA, Hoyer LL. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology. 2004;150:267–275.
   PubMed Web of Science ®Google Scholar
• Wang A, Wang CP, Tu M, Wong DTW. Oral biofluid biomarker research: current status and emerging frontiers. Diagnostics. 2016;6:45.
   Web of Science ®Google Scholar
• Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C. Diagnostic potential of saliva: current state and future applications. Clin Chem. 2011;57:675–687. doi:10.1373/clinchem.2010.153767.
   PubMed Web of Science ®Google Scholar
• Klemetsrud T, Kjøniksen AL, Hiorth M, Jacobsen J, Smistad G. Polymer coated liposomes for use in the oral cavity–a study of the in vitro toxicity, effect on cell permeability and interaction with mucin. J Liposome Res. 2018;28:62–73. doi:10.1080/08982104.2016.1255640.
   PubMed Web of Science ®Google Scholar
• Teubl BJ, Absenger M, Fröhlich E, Leitinger G, Zimmer A, Roblegg E. The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model. Eur J Pharm Biopharm. 2013;84:386–393.
   PubMed Web of Science ®Google Scholar
• Portero A, Remuñán-López C, Nielsen HM. The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model - An in vitro model of the buccal epithelium. Pharm Res. 2002;19:169–174. doi:10.1023/A:1014220832384.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Choi MJ, Bak DH, Lee BC, Ko EJ, Ahn GR, Ahn SW, Kim MJ, Na J, Kim BJ. Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice. Sci Rep. 2018;8:1–11. doi:10.1038/s41598-017-17765-5.
   PubMed Web of Science ®Google Scholar
• Tang X, Liu H, Yang S, Li Z, Zhong J, Fang R. Epidermal growth factor and intestinal barrier function. Mediators Inflamm. 2016;2016:27–30.
   Web of Science ®Google Scholar
• Barabutis N, Khangoora V, Marik PE, Catravas JD. Hydrocortisone and ascorbic acid synergistically prevent and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. Chest. 2017;152:954–962. doi:10.1016/j.chest.2017.07.014.
   PubMed Web of Science ®Google Scholar
• Kürti L, Veszelka S, Bocsik A, Ózsvári B, Puskás LG, Kittel Á, Szabó-Révész P, Deli MA. Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability. Cytotechnology. 2013;65:395–406.
   PubMed Web of Science ®Google Scholar
• Schrot S, Weidenfeller C, Schäffer TE, Robenek H, Galla H-J. Influence of hydrocortisone on the mechanical properties of the cerebral endothelium in vitro. Biophys J. 2005;89:3904–3910. doi:10.1529/biophysj.104.058750.
   PubMed Web of Science ®Google Scholar
• Kılıc Y,  Cetin HN, Sumlu E, Pektas MB, Koca HB, Akar F. Effects of boxing matches on metabolic, hormonal, and inflammatory parameters in male elite boxers. Med. 2019;55:1–11.
   Google Scholar
• Cannizzaro E, Cirrincione L, Mazzucco W, Scorciapino A, Catalano C, Ramaci T, Ledda C, Plescia F. Night-time shift work and related stress responses: A study on security guards. Int J Environ Res Public Health. 2020;17:562. doi:10.3390/ijerph17020562.
   Web of Science ®Google Scholar
• Eckert RL, Rorke EA. Molecular biology of keratinocyte differentiation. Environ Health Perspect. 1989;80:109–116. doi:10.1289/ehp.8980109.
   PubMed Web of Science ®Google Scholar
• Reiss M, Pitman SW, Sartorelli AC. Modulation of the terminal differentiation of human squamous carcinoma cells in vitro by all-trans-retinoic acid1, 2. J Natl Cancer Inst. 1985;74:1015–1023.
   PubMed Web of Science ®Google Scholar
• Buckley A, Turner JR. Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb Perspect Biol. 2018;10:a029314. doi:10.1101/cshperspect.a029314.
   PubMed Web of Science ®Google Scholar
• Weber CR. Dynamic properties of the tight junction barrier. Ann N Y Acad Sci. 2012;1257:77–84. doi:10.1111/j.1749-6632.2012.06528.x.
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Anderson JM. Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol. 2014;36:157–165. doi:10.1016/j.semcdb.2014.08.011.
   PubMed Web of Science ®Google Scholar
• Tsukita S, Tanaka H, The Claudins: TA. From tight junctions to biological systems. Trends Biochem Sci. 2019;44:141–152. doi:10.1016/j.tibs.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Dos Reis PP, Bharadwaj RR, Machado J, MacMillan C, Pintilie M, Sukhai MA, Perez-Ordonez B, Gullane P, Irish J, Kamel-Reid S, et al. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma. Cancer. 2008;113:3169–3180.
   PubMed Web of Science ®Google Scholar
• Lourenço SV, Coutinho-Camillo CM, Buim MEC, Pereira CM, Carvalho AL, Kowalski LP, Soares FA. Oral squamous cell carcinoma: status of tight junction claudins in the different histopathological patterns and relationship with clinical parameters. A tissue-microarray-based study of 136 cases. J Clin Pathol. 2010;63:609–614.
   PubMed Web of Science ®Google Scholar
• Bayar GR, Aydintug YS, Gulses A, Elci P, Sarper M. A pilot study of the primary culture of the oral mucosa keratinocytes by the direct explant technique. Oral Health and Dental Management in Black Sea Countries. 2011;10:88–92.
   Google Scholar
• Peramo A, Marcelo CL, Feinberg SE. Tissue engineering of lips and muco-cutaneous junctions: in vitro development of tissue engineered constructs of oral mucosa and skin for lip reconstruction. Tissue Eng Part C Methods. 2012;18:273–282. doi:10.1089/ten.tec.2011.0406.
   PubMed Web of Science ®Google Scholar
• Donetti E, Bedoni M, Boschini E, Dellavia C, Barajon I, Gagliano N. Desmocollin 1 and desmoglein 1 expression in human epidermis and keratinizing oral mucosa: a comparative immunohistochemical and molecular study. Arch Dermatol Res. 2005;297:31–38.
   PubMed Web of Science ®Google Scholar
• Slomiany BL, Murty VLN, Piotrowski J, Slomiany A. Salivary mucins in oral mucosal defense. Gen Pharmacol. 1996;27(5):761–771. doi:10.1016/0306-3623(95)02050-0.
   PubMedGoogle Scholar
• Frenkel ES, Ribbeck K. Salivary mucins in host defense and disease prevention. J Oral Microbiol. 2015;7(1):29759. doi:10.3402/jom.v7.29759.
   PubMed Web of Science ®Google Scholar
• Sen S, Sharma S, Gupta A, Gupta N, Singh H, Roychoudhury A, Mohanty S, Sen S, Nag TC, Tandon R, et al. Molecular characterization of explant cultured human oral mucosal epithelial cells. Investig Ophthalmol Vis Sci. 2011;52:9548–9554.
   PubMed Web of Science ®Google Scholar
• Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, de Bolos C, Cardesa A. Expression of Membrane-Bound Mucins (MUC1 and MUC4) and Secreted Mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol. 2005;29:806–813. doi:10.1097/01.pas.0000155856.84553.c9.
   PubMed Web of Science ®Google Scholar
• Suh H, Valle S, Morris DL. Targeting MUC16 in cancer therapy. Chemother Open Access. 2017;06:6–10.
   Google Scholar
• Ukkonen H, Pirhonen P, Herrala M, Mikkonen JJW, Singh SP, Sormunen R, Kullaa AM. Oral mucosal epithelial cells express the membrane anchored mucin MUC1. Arch Oral Biol. 2017;73:269–273.
   PubMed Web of Science ®Google Scholar
• Kho HS. Oral epithelial MUC1 and oral health. Oral Dis. 2018;24:19–21. doi:10.1111/odi.12713.
   PubMed Web of Science ®Google Scholar
• Thakur A, Tupkari J, Joy T, Kende P, Siwach P, Ahire M. Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: an immunohistochemical study. J Oral Maxillofac Pathol. 2018;22:210–215.
   PubMedGoogle Scholar
• Louis NA, Hamilton KE, Canny G, Shekels LL, Ho SB, Colgan SP. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J Cell Biochem. 2006;99:1616–1627.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Bhattacharya A, Manhas J, Kholakiya Y, Khera N, Roychoudhury A, Sen S. Increased mucin expression in oral mucosal epithelial cells in vitro: a potential new role of mycophenolate mofetil. Tokai J Exp Clin Med. 2018;43:132–138.
   PubMedGoogle Scholar
• Bai Q, Liu L, Long Q, Xia Y, Wang J, Xu J, Guo J. Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:11005–11014.
   PubMedGoogle Scholar
• Simon GC, Martin RJ, Smith S, Thaikoottathil J, Bowler RP, Barenkamp SJ, Chu HW. Up-regulation of MUC18 in airway epithelial cells by IL-13 implications in bacterial adherence. Am J Respir Cell Mol Biol. 2011;44:606–613.
   PubMed Web of Science ®Google Scholar
• Wu Q, Case SR, Minor MN, Jiang D, Martin RJ, Bowler RP, Wang J, Hartney J, Karimpour-Fard A, Chu HW, et al. A novel function of MUC18: amplification of lung inflammation during bacterial infection. Am J Pathol. 2013;182:819–827.
   PubMed Web of Science ®Google Scholar
• Ma J, Rubin BK, Voynow JA. Mucins, mucus, and goblet cells. Chest. 2018;154:169–176. doi:10.1016/j.chest.2017.11.008.
   PubMed Web of Science ®Google Scholar
• Woodward AM, Argüeso P. Expression analysis of the transmembrane mucin MUC20 in human corneal and conjunctival epithelia. Investig Ophthalmol Vis Sci. 2014;55:6132–6138. doi:10.1167/iovs.14-15269.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang H, Shen L, Lin Y, Shi Q, Yang Y. The expression and prognostic significance of Mucin 13 and Mucin 20 in esophageal squamous cell carcinoma. J Cancer Res Ther. 2015;11:74–79.
   Web of Science ®Google Scholar
• Itoh Y, Kamata-Sakurai M, Denda-Nagai K, Nagai S, Tsuiji M, Ishii-Schrade K, Okada K, Goto A, Fukayama M, Irimura T, et al. Identification and expression of human epiglycanin/MUC21: a novel transmembrane mucin. Glycobiology. 2008;18:74–83.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tatakis DN. Human gingiva transcriptome during wound healing. 2016. doi:10.1111/jcpe.12669.
   Google Scholar
• Delporte C, Bryla A, Perret J. Aquaporins in salivary glands: from basic research to clinical applications. Int J Mol Sci. 2016;17:1–13. doi:10.3390/ijms17020166.
   Web of Science ®Google Scholar
• Poveda M, Hashimoto S, Matsuki-Fukushima M, Sasaki H, Sakurai K, Masaki S. Expression and localization of aqua-glyceroporins AQP3 and AQP9 in rat oral epithelia. Bull Tokyo Dent Coll. 2014;55:1–10.
   PubMedGoogle Scholar
• Wilkens S. Structure and mechanism of ABC transporters. F1000Prime Rep. 2015;7:1–9. doi:10.12703/P7-14.
   Google Scholar
• Marquez B, Van Bambeke F. ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. Curr Drug Targets. 2011;12:600–620. doi:10.2174/138945011795378504.
   PubMed Web of Science ®Google Scholar
• Lin DJH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics. Clin Pharmacokinet. 2012;42:59–98. doi:10.2165/00003088-200342010-00003.
   Google Scholar
• Peng R, Zhang H, Zhang Y, Wei DY. Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs. Xenobiotica. 2016;46:948–952. doi:10.3109/00498254.2016.1138249.
   PubMed Web of Science ®Google Scholar
• Paitz RT, Bukhari SA, Bell AM. Stickleback embryos use ATP-binding cassette transporters as a buffer against exposure to maternally derived cortisol. Proc R Soc B Biol Sci. 2016;283:1–7. doi:10.1098/rspb.2015.2838.
   Web of Science ®Google Scholar
• Burns VE, Kerppola TK. ATR-101 inhibits cholesterol efflux and cortisol secretion by ATP-binding cassette transporters, causing cytotoxic cholesterol accumulation in adrenocortical carcinoma cells. Br J Pharmacol. 2017;174:3315–3332. doi:10.1111/bph.13951.
   PubMed Web of Science ®Google Scholar
• Neary JP, Malbon L, McKenzie DC. Relationship between serum, saliva and urinary cortisol and its implication during recovery from training. J Sci Med Sport. 2002;5:108–114. doi:10.1016/S1440-2440(02)80031-7.
   PubMed Web of Science ®Google Scholar
• Turpeinen U, Hämäläinen E. Determination of cortisol in serum, saliva and urine. Best Pract Res Clin Endocrinol Metab. 2013;27:795–801. doi:10.1016/j.beem.2013.10.008.
   PubMed Web of Science ®Google Scholar
• Bicakci T, Ozcaka O, Tuzunsoy-aktas R, Nalbantsoy A, Akcali A, Bicakci N, Kose T. Effects of potassium aluminum sulfate on TNF-α, MMP −1 and MMP-8 levels at gingival crevicular fluid in periodontally healthy subjects: a pilot study. Turkish J Biochem. 2012;37:315–321.
   Google Scholar
• Iyengar A, Paulus JK, Gerlanc DJ, Maron JL. Detection and potential utility of C-reactive protein in saliva of neonates. Front Pediatr. 2014;2:1–6. doi:10.3389/fped.2014.00131.
   PubMed Web of Science ®Google Scholar